Ritter A, Poppinga J, Steinkraus K, Hackert T, Niessen A
Curr Oncol Rep. 2025; 27(2):157-167.
PMID: 39862354
PMC: 11861007.
DOI: 10.1007/s11912-024-01632-4.
Kostiainen I, Simonen P, Aaltonen K, Linden R, Karppinen N, Gordin D
Cancers (Basel). 2024; 16(23).
PMID: 39682084
PMC: 11639896.
DOI: 10.3390/cancers16233896.
Clement D, van Leerdam M, Tesselaar M, Srinivasan P, Menon K, Kuhlmann K
Nutrients. 2024; 16(22).
PMID: 39599579
PMC: 11597585.
DOI: 10.3390/nu16223790.
Meng Q, Halfdanarson T, Bornhorst J, Jann H, Shaheen S, Shi R
Clin Cancer Res. 2024; 30(24):5559-5567.
PMID: 39453770
PMC: 11647202.
DOI: 10.1158/1078-0432.CCR-24-1875.
Panzuto F, Albertelli M, De Rimini M, Rizzo F, Grana C, Cives M
J Endocrinol Invest. 2024; 48(1):23-36.
PMID: 39395114
PMC: 11729074.
DOI: 10.1007/s40618-024-02448-6.
The Clinical Utility of the NETest in Patients with Small Intestinal Neuroendocrine Neoplasms (Si-NENs): A "Real-Life" Study.
Gertner J, Tsoli M, Hayes A, OMahony L, Laskaratos F, Glover T
Cancers (Basel). 2024; 16(14).
PMID: 39061146
PMC: 11274476.
DOI: 10.3390/cancers16142506.
Co-existing Neuroendocrine Tumors in the Ileum and Pancreas: A Clinico-Pathological Challenge.
Laffi A, Bertuzzi A, Carrara S, Zerbi A, Lania A, Lavezzi E
Endocr Pathol. 2024; 35(3):256-266.
PMID: 38848012
DOI: 10.1007/s12022-024-09814-3.
[Local resection of small intestine neuroendocrine neoplasms (SI-NEN) : Current principles].
Maurer E, Bartsch D
Chirurgie (Heidelb). 2024; 95(10):818-824.
PMID: 38771340
DOI: 10.1007/s00104-024-02102-0.
Radio-Guided Surgery with a New-Generation β-Probe for Radiolabeled Somatostatin Analog, in Patients with Small Intestinal Neuroendocrine Tumors.
Bertani E, Mattana F, Collamati F, Ferrari M, Bagnardi V, Frassoni S
Ann Surg Oncol. 2024; 31(7):4189-4196.
PMID: 38652200
DOI: 10.1245/s10434-024-15277-x.
Gastric neuroendocrine neoplasms.
Lamberti G, Panzuto F, Pavel M, OToole D, Ambrosini V, Falconi M
Nat Rev Dis Primers. 2024; 10(1):25.
PMID: 38605021
DOI: 10.1038/s41572-024-00508-y.
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.
Melhorn P, Mazal P, Wolff L, Kretschmer-Chott E, Raderer M, Kiesewetter B
Ther Adv Med Oncol. 2024; 16:17588359241240316.
PMID: 38529270
PMC: 10962050.
DOI: 10.1177/17588359241240316.
Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumors.
Daskalakis K, Tsoli M, Wallin G, Kogut A, Srirajaskanthan R, Harlow C
J Clin Endocrinol Metab. 2024; 109(12):e2222-e2230.
PMID: 38415861
PMC: 11570380.
DOI: 10.1210/clinem/dgae111.
The Role of Capsule Endoscopy in the Diagnosis and Management of Small Bowel Tumors: A Narrative Review.
Fantasia S, Cortegoso Valdivia P, Kayali S, Koulaouzidis G, Pennazio M, Koulaouzidis A
Cancers (Basel). 2024; 16(2).
PMID: 38254753
PMC: 10813471.
DOI: 10.3390/cancers16020262.
Comparison of Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors.
Drucker Iarovich M, Hinzpeter R, Moloney B, Hueniken K, Veit-Haibach P, Ortega C
Curr Oncol. 2024; 31(1):521-534.
PMID: 38248121
PMC: 10813973.
DOI: 10.3390/curroncol31010036.
ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms.
Hallet J, Clarke C
Ann Surg Oncol. 2024; 31(3):1704-1713.
PMID: 38167813
DOI: 10.1245/s10434-023-14802-8.
Evaluation of quality of clinical management of neuroendocrine tumors.
Bloemen H, Kneepkens K, Deraedt K, Ivanova A, Sergeant G, Mebis J
Cancer Innov. 2023; 1(4):305-315.
PMID: 38089084
PMC: 10686178.
DOI: 10.1002/cai2.41.
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
Mulders M, de Herder W, Hofland J
Endocr Rev. 2023; 45(3):351-360.
PMID: 38038364
PMC: 11074795.
DOI: 10.1210/endrev/bnad035.
Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors.
Nigam A, Li J, Fiasconaro M, Lin S, Capanu M, Kleiman D
Ann Surg Oncol. 2023; 31(4):2337-2348.
PMID: 38036927
DOI: 10.1245/s10434-023-14637-3.
Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.
Soreide K, Stattner S, Hallet J
Ann Surg Oncol. 2023; 31(2):1125-1137.
PMID: 38006527
PMC: 10761444.
DOI: 10.1245/s10434-023-14610-0.
Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review.
Kmiotek E, Lakda S, Borakati A, Ogunbiyi O, Mandair D, Caplin M
Curr Oncol. 2023; 30(10):9192-9204.
PMID: 37887564
PMC: 10605700.
DOI: 10.3390/curroncol30100664.
